Radiotherapy with carboplatin

OTHER2 trials

Sponsors

Universitätsklinikum Hamburg-Eppendorf, Centre Antoine Lacassagne

Conditions

Brain TumorsHead and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1

Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)

WithdrawnNCT03114280

Centre Antoine LacassagneHead and Neck Squamous Cell Carcinoma (HNSCC)

Start: 2019-03-12End: 2019-03-12Updated: 2019-04-08

Phase 2

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Active, not recruitingNCT02066220

Universitätsklinikum Hamburg-EppendorfBrain Tumors

Start: 2014-06-30End: 2026-12-31Target: 360Updated: 2025-12-04

Related Papers

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.

2018-11-0171 citations